TYK2| RhAPP

top of page

Content Rheum

TYK2

FAQs

Describe the TYK2/STAT signaling pathway and immunologic rationale for TYK2 directed therapy for the treatment of psoriasis and psoriatic arthritis.

How does the selectivity of TYK2 and JAK enzyme inhibition influence their safety profiles

Medication Review_v2.png

MEDICATION REVIEWS

What is the mechanism of action of deucravacitinib?

What is the safety profile of deucravactinib in PsO and PsA?

JOURNAL CLUBS

A review of the safety and efficacy of deucravacitinib for plaque psoriasis: an expert consensus panel

PODCASTS

Understanding the TYK2/STAT signaling pathway in PsA: clinical implications and beyond

Become a RhAPP Member

bottom of page